LOCALIZATION OF M(3) MUSCARINIC RECEPTOR SUBTYPE AND MESSENGER-RNA IN THE HUMAN EYE

被引:34
作者
GUPTA, N [1 ]
DRANCE, SM [1 ]
MCALLISTER, R [1 ]
PRASAD, S [1 ]
ROOTMAN, J [1 ]
CYNADER, MS [1 ]
机构
[1] FAC MED VANCOUVER,DEPT OPHTHALMOL,CTR EYE CARE,EYE RES LAB,VANCOUVER,BC,CANADA
关键词
GLAUCOMA; ACETYLCHOLINE; CILIARY MUSCLE; IRIS; CORNEA; TRABECULAR MESHWORK; CILIARY EPITHELIUM; IN SITU HYBRIDIZATION; AUTORADIOGRAPHY;
D O I
10.1159/000267472
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Cholinergic agents used to lower intraocular pressure in the medical management of glaucoma act on muscarinic receptors in the eye. Recently, subtypes of muscarinic receptors have been recognized in many tissues including the eye. To localize the M(3) muscarinic receptor subtype and m(3) messenger RNA (mRNA) in the human eye, we used in vitro ligand binding and in situ hybridization techniques on post-mortem sections. We used an M(3) antagonist, [H-3]-4-DAMP ([H-3]-4-diphenylacetoxy-N-methylpiperidine methiodide) to identify M(3)-binding sites and a [S-35]-labelled oligonucleotide probe to detect and localize m(3) mRNA. M(3) and m(3) mRNA were both localized in the ciliary muscle, ciliary epithelium, iris, corneal epithelium and anterior lens epithelium. The m(3) transcript was also detected in the trabecular meshwork and corneal endothelium.
引用
收藏
页码:207 / 213
页数:7
相关论文
共 24 条
[1]   IDENTIFICATION OF A FAMILY OF MUSCARINIC ACETYLCHOLINE-RECEPTOR GENES [J].
BONNER, TI ;
BUCKLEY, NJ ;
YOUNG, AC ;
BRANN, MR .
SCIENCE, 1987, 237 (4814) :527-532
[2]   CLONING AND EXPRESSION OF THE HUMAN AND RAT M5 MUSCARINIC ACETYLCHOLINE-RECEPTOR GENES [J].
BONNER, TI ;
YOUNG, AC ;
BRANN, MR ;
BUCKLEY, NJ .
NEURON, 1988, 1 (05) :403-410
[3]  
BUCKLEY NJ, 1989, MOL PHARMACOL, V35, P469
[4]  
CAVANAGH HD, 1982, METAB PEDIATR SYST O, V6, P63
[5]  
CHEN J, 1988, FASEB J, V2, pA788
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]  
COLLEY AM, 1982, METAB PEDIATR SYST O, V6, P75
[8]  
DODDS HN, 1987, J PHARMACOL EXP THER, V242, P257
[9]  
GABELT BT, 1992, J PHARMACOL EXP THER, V263, P1133
[10]  
GIL DW, 1991, INVEST OPHTH VIS SCI, V32, P1256